Despite higher revenue guidance for FY25, Ipca Laboratories Ltd’s stock plunges by 7.78% to $1,152.15.
The drop of 8.23% is attributed to brokerages slashing the target price due to poor Q4 performance.
Management anticipates an 18% margin in FY25E, projected to increase to ~21% in FY27E.
IPCALAB has yielded a solid 78.24% return over the past year.
RHI Magnesita India Ltd at Stock Market
RHI Magnesita India Ltd
₹714.20/-
RHI Magnesita India Reports Strong Q4 Results
RHI Magnesita India Ltd reduces net losses in Q4FY24 to approximately ₹258 crore, marking a remarkable YoY improvement of 62%.
Revenue from operations grows by 8% YoY to ₹943.3 crore in the final quarter of FY24.
Despite a 3.97% decline in stock value, RHIM has provided an impressive 226.98% return over the past five years.
Bharat Rasayan Ltd
₹10,573.85/-
Bharat Rasayan Reports Strong Q4 Results
Bharat Rasayan Ltd’s Q4FY24 net profit surges by 122% YoY to Rs. 67.1 crore, while revenues from operations see a slight 1.2% YoY increase to Rs. 309.6 crore.
The company announces a final dividend of Rs. 1.5 per share on fully paid-up equity shares for FY23-24.
Strong financial results and dividend declaration may bolster investor confidence in Bharat Rasayan Ltd.
Despite a -7.04% return over the past year, BHARATRAS has potential for growth with positive quarterly performance.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of News Lounge 24×7. We advise investors to check with certified experts before taking any investment decisions.
Pampum is a digital content editor and news analyst with experience covering Indian current affairs, public policy, and governance. Focusing on simplifying complex developments for general readers while maintaining factual accuracy and editorial balance.
Areas of coverage include government policy, legal affairs, and socio-economic issues.